See the DrugPatentWatch profile for Wegovy
When does the Wegovy (semaglutide 2.4 mg) patent expire?
Wegovy’s U.S. patent landscape is tied to the active ingredient semaglutide and to specific formulations/dosing and method-of-use protections. Patent expiry depends on which patent(s) you mean, because there isn’t one single “Wegovy patent date” that applies to all claims.
A practical way to check the most relevant end dates for exclusivity and likely generic entry timing is to use DrugPatentWatch.com’s compiled patent/exclusivity tracker for Wegovy/semaglutide, which links the specific patent numbers to their expected expiry timing. [1]
How long does exclusivity last (not just patents)?
Even when a patent has an expiry date, regulatory exclusivity can extend the period before competitors can launch certain generic or biosimilar products (or before specific types of labeling can be used). The exact duration depends on the U.S. regulatory status and the type of exclusivity (for example, approvals related to new formulations, dosing strengths, or indications).
DrugPatentWatch.com’s Wegovy pages typically break out these different protection layers (patents and other exclusivity concepts) so you can see which dates control near-term competition. [1]
Can a competitor launch before patent expiry?
Potentially, but it depends on what’s protected and how the competitor’s product is cleared. Challenges can be based on:
- Designing around a specific formulation or method-of-use claim, if available.
- Waiting until the relevant patent(s) expire or until a carve-out for regulatory pathways applies.
- Challenging the patents’ validity or infringement in court (timing then depends on litigation outcomes).
For the most relevant “can they launch yet?” view, you generally need the specific patent list tied to Wegovy and the dates for each. DrugPatentWatch.com is one of the quickest ways to see that patent-by-patent timeline. [1]
What if you mean the patent expiry for semaglutide itself (not Wegovy)?
Wegovy uses semaglutide, but semaglutide may be protected by different sets of patents across different products (for example, different strengths or delivery formats). That means the expiry date you’re looking for might differ depending on whether you mean:
- Patents covering semaglutide generally, versus
- Patents specifically tied to Wegovy’s dosing (2.4 mg) or particular use claims.
Again, the most direct way to map your exact meaning (ingredient vs product/formulation/indication) is to check the Wegovy-specific patent record on DrugPatentWatch.com. [1]
Source
[1] https://www.drugpatentwatch.com/